Cargando…
Alzheimer’s Disease: Understanding Its Novel Drug Delivery Systems and Treatments
Around the world, there are no fewer than 24 million people who suffer from dementia. Through 2040, this number is expected to rise steadily every 20 years. Alzheimer's disease (AD), the most prevalent kind of dementia, is characterised by a steady deterioration in cognitive function that most...
Autores principales: | Dhingra, Hitaansh, Choudhari, Sonali G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744405/ https://www.ncbi.nlm.nih.gov/pubmed/36523713 http://dx.doi.org/10.7759/cureus.31394 |
Ejemplares similares
-
Huntington’s Disease: Understanding Its Novel Drugs and Treatments
por: Dhingra, Hitaansh, et al.
Publicado: (2023) -
Treatment with imatinib improves drug delivery and efficacy in NSCLC xenografts
por: Vlahovic, G, et al.
Publicado: (2007) -
Can commonly prescribed drugs be repurposed for the prevention or treatment of Alzheimer's and other neurodegenerative diseases? Protocol for an observational cohort study in the UK Clinical Practice Research Datalink
por: Walker, Venexia M, et al.
Publicado: (2016) -
Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery
por: PosthumaDeBoer, J, et al.
Publicado: (2013) -
Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study
por: Arends, Maarten, et al.
Publicado: (2018)